Y-Intercept (HK)
ANIP icon

Y-Intercept (HK)’s ANI Pharmaceuticals ANIP Stock Holding History

Y-Intercept (HK)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-34,505
Closed -$2.86M – 1566
2026
Q2 		$2.86M Buy
34,505
+25,082
+266% +$2.01M 0.06% 503
2026
Q1 		$725K Sell
9,423
-35,983
-79% -$2.81M 0.01% 1147
2025
Q4 		$3.58M Buy
45,406
+37,716
+490% +$3.27M 0.08% 345
2025
Q3 		$704K Buy
+7,690
New +$627K 0.02% 1129
2024
Q4 		– Sell
-6,781
Closed -$405K – 1153
2024
Q3 		$405K Buy
+6,781
New +$414K 0.02% 879

Other funds holding ANIP

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Quartz Partners
Quartz Partners Saratoga Springs, New York $330M AUM 17.57% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Y-Intercept (HK)'s ANIP Position: Q3 2026 in Review

Y-Intercept (HK) sold out of ANI Pharmaceuticals (ANIP) in Q3 2026, closing a stake of 34,505 shares — an estimated $2.86M sold.

Y-Intercept (HK) first reported a position in ANIP in Q3 2024 and held it in 5 quarters. The position peaked at $3.58M in Q4 2025. 72 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Y-Intercept (HK) reported no remaining ANI Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 34,505 ANI Pharmaceuticals shares in Q3 2026, an estimated $2.86M.
  • Y-Intercept (HK) first reported a position in ANI Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Y-Intercept (HK)'s ANI Pharmaceuticals position peaked at $3.58M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.